JEFFREY HERNANDEZ: Open Payments
NPI 1619442910 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$26,649 in 51 payments from 9 companies in 2025. Trend: 2023 $39,924 · 2024 $24,900 · 2025 $26,649
Speaker / faculty: $11,873Consulting: $10,179Travel & lodging: $2,822Food & beverage: $1,776
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. | 14 | $7,448 |
| Amgen Inc. | 13 | $6,917 |
| GENZYME CORPORATION | 6 | $6,352 |
| Genentech USA, Inc. | 6 | $3,985 |
| EMD Serono, Inc. | 3 | $1,375 |
| Novartis Pharmaceuticals Corporation | 2 | $401 |
| Alexion Pharmaceuticals, Inc. | 4 | $82 |
| Celgene Corporation | 2 | $55 |
| Biogen, Inc. | 1 | $33 |
Products named: BRIUMVI, UPLIZNA, Ocrevus, Mavenclad, KESIMPTA, ULTOMIRIS, ZEPOSIA, TYSABRI.
Industry payments across FL — which companies pay providers there.
